Healthcare ❯Pharmaceuticals ❯Drug Approval

FDA

Bristol Myers Squibb Lenacapavir Johnson & Johnson Clinical Trials Neffy SPRAVATO Global Health Monoclonal Antibodies Esketamine New Drug Mechanisms

5 ARTICLES

last wk.

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

With global HIV funding dwindling, a Gilead-Global Fund agreement secures two million no-profit lenacapavir doses for low- and middle-income countries.

3 ARTICLES

last mo.

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

FDA

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

FDA Approves First Standalone Nasal Spray for Treatment-Resistant Depression

FDA Approves First Nasal Spray for Treatment-Resistant Depression

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis